SCHEMBL31368569

SCHEMBL31368569

Cc1cc(C(=O)O)cc(S(C)(=O)=O)n1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TPMT P51580 1/20 0.42
▸ ALOX15 P16050 1/20 0.41
▸ TSHR P16473 1/20 0.41
▸ HIF1A Q16665 1/20 0.41
▸ SMN1; SMN2 Q16637 4/20 0.39
▸ NPC1 O15118 2/20 0.39
▸ RAB9A P51151 2/20 0.39
▸ LCK P06239 1/20 0.38
▸ FYN P06241 1/20 0.38
▸ ALDH1A1 P00352 4/20 0.38
▸ MAPK1 P28482 2/20 0.38
▸ HCAR1 Q9BXC0 1/20 0.37
▸ TDP1 Q9NUW8 1/20 0.37
▸ HCAR2 Q8TDS4 1/20 0.36
▸ LMNA P02545 1/20 0.36
▸ AKR1C3 P42330 1/20 0.35
▸ HTT P42858 1/20 0.35
▸ CA12 O43570 1/20 0.34
▸ CA1 P00915 1/20 0.34
▸ CA2 P00918 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12166934 1.00 TPMT (0.42) TPMTALOX15TSHRHIF1ASMN1; SMN2
SCHEMBL10949551 0.88 ALOX15 (0.46) TPMTALOX15TSHRHIF1ASMN1; SMN2
Hydrochloric Acid SCHEMBL10573659 0.86 ALOX15 (0.45) TPMTALOX15TSHRHIF1ASMN1; SMN2
SCHEMBL1348688 0.84 POLB (0.40) SMN1; SMN2ALDH1A1LMNAHTTCA12
SCHEMBL1498369 0.80 GPBAR1 (0.47) SMN1; SMN2RAB9ALCKFYNALDH1A1
SCHEMBL1179149 0.80 TPMT (0.56) TPMTALOX15TSHRHIF1ASMN1; SMN2
Hydrochloric Acid SCHEMBL1179035 0.78 TPMT (0.54) TPMTALOX15TSHRHIF1ASMN1; SMN2
Hydrochloric Acid SCHEMBL11078337 0.78 TPMT (0.54) TPMTALOX15TSHRHIF1ASMN1; SMN2
SCHEMBL3439357 0.77 KDM4E (0.51) TPMTALOX15TSHRHIF1ASMN1; SMN2
SCHEMBL24773614 0.76 LMNA (0.36) ALOX15TSHRHIF1ASMN1; SMN2LCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4739685-A1 1,6-NAPHTHRIDINE COMPOUNDS AS SMARCA2 INHIBITORS USEFUL FOR THE TREATMENT OF SMARCA4 DEFICIENT CANCERS Janssen Pharmaceutica NV (BE) 2026-05-13 — — EP disclosed
WO-2025008061-A1 1,6-NAPHTHRIDINE COMPOUNDS AS SMARCA2 INHIBITORS USEFUL FOR THE TREATMENT OF SMARCA4 DEFICIENT CANCERS JANSSEN PHARMACEUTICA NV (BE) 2025-01-09 — — WO disclosed
Send feedback